Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Ophthalmic Suspension Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Antibiotic
  • 1.3.3 Antifungal
  • 1.3.4 Antibacterial
  • 1.3.5 Steroids
  • 1.3.6 NSAIDs
• 1.4 Market Segment by Application
  • 1.4.1 Global Ophthalmic Suspension Market Share by Application (2019-2025)
  • 1.4.2 Bacterial Infections
  • 1.4.3 Retinal Disorders
  • 1.4.4 Glaucoma
  • 1.4.5 Allergies
  • 1.4.6 Diabetic Eye Disease
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Ophthalmic Suspension Market Size
  • 2.1.1 Global Ophthalmic Suspension Revenue 2014-2025
  • 2.1.2 Global Ophthalmic Suspension Sales 2014-2025
• 2.2 Ophthalmic Suspension Growth Rate by Regions
  • 2.2.1 Global Ophthalmic Suspension Sales by Regions 2014-2019
  • 2.2.2 Global Ophthalmic Suspension Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Ophthalmic Suspension Sales by Manufacturers
  • 3.1.1 Ophthalmic Suspension Sales by Manufacturers 2014-2019
  • 3.1.2 Ophthalmic Suspension Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Ophthalmic Suspension Revenue by Manufacturers (2014-2019)
  • 3.2.2 Ophthalmic Suspension Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Ophthalmic Suspension Market Concentration Ratio (CR5 and HHI)
• 3.3 Ophthalmic Suspension Price by Manufacturers
• 3.4 Key Manufacturers Ophthalmic Suspension Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Ophthalmic Suspension Market
• 3.6 Key Manufacturers Ophthalmic Suspension Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Antibiotic Sales and Revenue (2014-2019)
  • 4.1.2 Antifungal Sales and Revenue (2014-2019)
  • 4.1.3 Antibacterial Sales and Revenue (2014-2019)
  • 4.1.4 Steroids Sales and Revenue (2014-2019)
  • 4.1.5 NSAIDs Sales and Revenue (2014-2019)
• 4.2 Global Ophthalmic Suspension Sales Market Share by Type
• 4.3 Global Ophthalmic Suspension Revenue Market Share by Type
• 4.4 Ophthalmic Suspension Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Ophthalmic Suspension Sales by Application

6 United States

• 6.1 United States Ophthalmic Suspension Breakdown Data by Company
• 6.2 United States Ophthalmic Suspension Breakdown Data by Type
• 6.3 United States Ophthalmic Suspension Breakdown Data by Application

7 European Union

• 7.1 European Union Ophthalmic Suspension Breakdown Data by Company
• 7.2 European Union Ophthalmic Suspension Breakdown Data by Type
• 7.3 European Union Ophthalmic Suspension Breakdown Data by Application

8 China

• 8.1 China Ophthalmic Suspension Breakdown Data by Company
• 8.2 China Ophthalmic Suspension Breakdown Data by Type
• 8.3 China Ophthalmic Suspension Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Ophthalmic Suspension Breakdown Data by Company
• 9.2 Rest of World Ophthalmic Suspension Breakdown Data by Type
• 9.3 Rest of World Ophthalmic Suspension Breakdown Data by Application
• 9.4 Rest of World Ophthalmic Suspension Breakdown Data by Countries
  • 9.4.1 Rest of World Ophthalmic Suspension Sales by Countries
  • 9.4.2 Rest of World Ophthalmic Suspension Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Allergan
  • 10.1.1 Allergan Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Ophthalmic Suspension
  • 10.1.4 Ophthalmic Suspension Product Introduction
  • 10.1.5 Allergan Recent Development
• 10.2 Merck
  • 10.2.1 Merck Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Ophthalmic Suspension
  • 10.2.4 Ophthalmic Suspension Product Introduction
  • 10.2.5 Merck Recent Development
• 10.3 Novartis
  • 10.3.1 Novartis Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Ophthalmic Suspension
  • 10.3.4 Ophthalmic Suspension Product Introduction
  • 10.3.5 Novartis Recent Development
• 10.4 Bausch & Lomb
  • 10.4.1 Bausch & Lomb Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Ophthalmic Suspension
  • 10.4.4 Ophthalmic Suspension Product Introduction
  • 10.4.5 Bausch & Lomb Recent Development
• 10.5 Falcon Group
  • 10.5.1 Falcon Group Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Ophthalmic Suspension
  • 10.5.4 Ophthalmic Suspension Product Introduction
  • 10.5.5 Falcon Group Recent Development
• 10.6 Pfizer
  • 10.6.1 Pfizer Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Ophthalmic Suspension
  • 10.6.4 Ophthalmic Suspension Product Introduction
  • 10.6.5 Pfizer Recent Development
• 10.7 Valeant
  • 10.7.1 Valeant Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Ophthalmic Suspension
  • 10.7.4 Ophthalmic Suspension Product Introduction
  • 10.7.5 Valeant Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Ophthalmic Suspension Sales Channels
  • 11.2.2 Ophthalmic Suspension Distributors
• 11.3 Ophthalmic Suspension Customers

12 Market Forecast

• 12.1 Global Ophthalmic Suspension Sales and Revenue Forecast 2019-2025
• 12.2 Global Ophthalmic Suspension Sales Forecast by Type
• 12.3 Global Ophthalmic Suspension Sales Forecast by Application
• 12.4 Ophthalmic Suspension Forecast by Regions
  • 12.4.1 Global Ophthalmic Suspension Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Ophthalmic Suspension Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone) is a combination of two antibiotics and a steroid used to treat bacterial infections of the eyes. Ophthalmic Suspension is available in generic form.
Increasing prevalence of eye diseases across the globe is one of the major factors contributing to the growth of this market. Moreover, increasing geriatric population which are most prone to eye disorders, and growing number of bacterial infections cases in children will also boost the growth of the market. Furthermore, according to WHO (2014), glaucoma is the second major cause of blindness in the world which will increase the market growth.
In 2019, the market size of Ophthalmic Suspension is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ophthalmic Suspension.

This report studies the global market size of Ophthalmic Suspension, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ophthalmic Suspension sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Allergan
Merck
Novartis
Bausch & Lomb
Falcon Group
Pfizer
Valeant
...

Market Segment by Product Type
Antibiotic
Antifungal
Antibacterial
Steroids
NSAIDs

Market Segment by Application
Bacterial Infections
Retinal Disorders
Glaucoma
Allergies
Diabetic Eye Disease

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Ophthalmic Suspension status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ophthalmic Suspension manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Ophthalmic Suspension are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025